The news brief “Microbes unite Novozymes and Monsanto” (32, 211, 2014) incorrectly states that BioAg Alliance's work involves microbial enzymes. The alliance will discover, develop and commercialize microbial solutions for agriculture. The error has been corrected in the HTML and PDF versions of the article.
In the news analysis “Master Protocol for squamous cell lung cancer readies for launch” (32, 116–118, 2014), Genentech's compound taselisib was incorrectly labeled as pictilisib in Table 1. The error has been corrected in the HTML and PDF versions of the article.
In the news analysis “Engineered tracheas, corneas and arteries enter clinical testing” (32, 303–304, 2014), the article incorrectly stated there was one case of rejection in a phase 1 trial of corneal implants, when there were none. There was one case of rejection in the control group that received donor corneas. The error has been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nbt0314-211b
Rights and permissions
About this article
Cite this article
Corrections. Nat Biotechnol 32, 601 (2014). https://doi.org/10.1038/nbt0714-601b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0714-601b
